Critical Care
RSSArticles
-
Kawasaki Disease
Kawasaki disease, first described by Dr. Tomisaku Kawasaki in 1967, is a self-limited systemic inflammatory vasculitis characterized by fever and a variety of mucocutaneous manifestations. Surpassing rheumatic heart disease, it is now the leading cause of acquired cardiac disease in children. -
Tick-borne Illness in the ED: Part I
Lyme disease is the most common vector disease. It often presents with erythema chronicum migrans in its earliest and most treatable stage.
-
Emergency Medicine Reports - Full February 9, 2014 Issue in PDF
-
Effects of ICU Capacity Strain on Patient Outcomes and ICU Discharge Timing
-
Reducing Antibiotic Overuse: An Intervention with Positive Outcomes
-
To Transfuse or Not Transfuse
In 1818, James Blundell performed the first successful human blood transfusion in a woman with postpartum hemorrhage. Nearly 200 years later, about 15 million red blood cell (RBC) units are transfused annually in the United States. Many of these transfusions occur in the intensive care unit (ICU), where up to 30-50% of patients are transfused. Despite the frequency of RBC transfusions, there is little evidence that transfusions benefit patients. -
Pediatric Emergency Medicine Reports - Full March 2014 Issue in PDF
-
Diagnosis and Management of Respiratory Syncytial Virus in the Emergency Department
-
Emergency Medicine Reports - Full March 9, 2014 Issue in PDF
-
Massive Transfusion: Part I
This is a two-part article on the treatment of massive hemorrhage, which is something that can be seen in any emergency department, small or large, rural or urban. There have been recent changes in the use of blood and adjuvant therapies, in part from our military advances. These articles will review the current recommendations for massive transfusion. Part II of the article will review adjunct therapies, scoring systems, and complications of massive transfusion.